These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 7178586

  • 1. [Biochemical changes in patients with chronic renal insufficiency during hemodialysis depending on whether or not they received 25-(OH)D3].
    Rico H, Naranjo P, Paniagua MC, Cordero M, Bordiu E, Charro A.
    Rev Clin Esp; 1982 Oct 15; 167(1):45-7. PubMed ID: 7178586
    [No Abstract] [Full Text] [Related]

  • 2. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
    Broulík P, Hrubý M.
    Cas Lek Cesk; 1993 Nov 22; 132(22):681-3. PubMed ID: 8293434
    [Abstract] [Full Text] [Related]

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 22; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 4. Parathyroid function after kidney allografting.
    Tajima A, Ishikawa A, Ohta N, Suzuki K, Kawabe K, Aso Y.
    Transplant Proc; 1996 Jun 22; 28(3):1629-30. PubMed ID: 8658814
    [No Abstract] [Full Text] [Related]

  • 5. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
    Pistor K, Reinhardt D, Grosse-Hohmann E, Keck E.
    Monatsschr Kinderheilkd; 1982 Sep 22; 130(9):714-20. PubMed ID: 6755227
    [Abstract] [Full Text] [Related]

  • 6. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH, Huang TS, Hsieh SJ.
    Miner Electrolyte Metab; 1996 Sep 22; 22(4):219-23. PubMed ID: 8807625
    [Abstract] [Full Text] [Related]

  • 7. Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy.
    O'Riordan JL, Page J, Kerr DN, Walls J, Moorhead J, Crockett RE, Franz H, Ritz E.
    Q J Med; 1970 Jul 22; 39(155):359-76. PubMed ID: 5478506
    [No Abstract] [Full Text] [Related]

  • 8. Clinical and metabolic effects of long-term treatment with 25(OH)D3 in hemodialysis.
    Coratelli P, Petrarulo F, Giannattasio M, Buongiorno E, Passavanti G, Antonelli G, Capurso A, Ferrannini E, Amerio A.
    Contrib Nephrol; 1985 Jul 22; 49():20-31. PubMed ID: 3830567
    [No Abstract] [Full Text] [Related]

  • 9. [Calcium-phosphate metabolism in chronic polyarthritis].
    Siegmeth W, Dudczak R, Zazgornik J.
    Z Rheumatol; 1982 Jul 22; 41(1):16-8. PubMed ID: 7080689
    [Abstract] [Full Text] [Related]

  • 10. Changes in serum phosphorus, calcium and alkaline phosphatase due to sucralfate.
    Vucelić B, Hadzić N, Gragas J, Puretić Z.
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb 22; 24(2):93-6. PubMed ID: 3514490
    [Abstract] [Full Text] [Related]

  • 11. Short-term effects of renal transplantation on the metabolism of vitamin D3.
    Saha H, Salmela K, Ahonen J, Pietilä K, Mörsky P, Pasternack A.
    Transplant Proc; 1992 Feb 22; 24(1):367-8. PubMed ID: 1539320
    [No Abstract] [Full Text] [Related]

  • 12. Serum osteocalcin and vitamin D in postmenopausal diabetic azotemics.
    Lu KC, Shieh SD, Chyr SH, Lin SH, Li BL, Diang LK, Chen WQ, Lin YF.
    Diabetes Res; 1993 Feb 22; 22(3):97-104. PubMed ID: 8076446
    [Abstract] [Full Text] [Related]

  • 13. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM, Youssef AM, Zayoon MY.
    Hemodial Int; 2006 Oct 22; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [Abstract] [Full Text] [Related]

  • 14. [Influence of hemodialysis on the concentration of parathyroid hormone in acute kidney failure].
    Kotot F, Kuska J.
    Z Gesamte Inn Med; 1974 Nov 15; 29(22):916-9. PubMed ID: 4462346
    [No Abstract] [Full Text] [Related]

  • 15. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
    Aresté N, Amor J, Cambil T, Salgueira M, Sánchez-Palencia R, Páez C, Gómez O, Palma A.
    Nefrologia; 2003 Nov 15; 23 Suppl 2():64-8. PubMed ID: 12778857
    [Abstract] [Full Text] [Related]

  • 16. Spermatogenesis after parathyroidectomy in patients with symptomatic secondary hyperparathyroidism.
    Chou FF, Lee CH, Lee CT, Huang FJ, Hsu KL.
    J Am Coll Surg; 2003 Jun 15; 196(6):854-8. PubMed ID: 12788420
    [Abstract] [Full Text] [Related]

  • 17. Ratio of parathyroid hormone to 1,25-dihydroxycholecalciferol in early renal failure.
    Lucas PA, Brown RC, Woodhead JS, Coles GA.
    Kidney Int Suppl; 1983 Dec 15; 16():S171-4. PubMed ID: 6588249
    [No Abstract] [Full Text] [Related]

  • 18. Effects of 25(OH)-vitamin D3 in hypocalcemic patients on chronic hemodialysis.
    Kronfol NO, Hersh WR, Barakat MM.
    ASAIO Trans; 1987 Dec 15; 33(3):289-92. PubMed ID: 3675956
    [No Abstract] [Full Text] [Related]

  • 19. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J, Piecha G, Kokot F, Wiecek A.
    J Nephrol; 2003 Dec 15; 16(5):710-5. PubMed ID: 14733418
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.